Literature DB >> 653309

Immunological family studies in Hodgkin's disease. Is the immunodeficiency horizontally transmitted?

M Björkholm, G Holm, H Mellstedt.   

Abstract

27 consanguineous and non-consanguineous relatives to 12 patients with Hodgkin's disease (HD) have been studied. The lymphocyte DNA synthesis induced by concanavalin (ConA) was depressed in 6 patients. 7 out of 15 tested relatives (3 first degree relatives and 4 spouses) showed a profound impairment in lymphocyte response to ConA stimulation. None out of 12 relatives to ConA normal patients was defect in this respect. In relatives to ConA hyporesponsive patients there was a small but statistically significant decrease in lymphocyte response to pokeweed mitogen (PWM) and PPD in vitro. No differences in lymphocyte subpopulations were seen. The findings strongly support an exogenous factory (probably a virus) causing the depressed mitogen response in relatives to immunodeficient patients with HD. A possible linkage between the immunodeficiency and the pathogenesis of HD is discussed.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 653309     DOI: 10.1111/j.1600-0609.1978.tb02461.x

Source DB:  PubMed          Journal:  Scand J Haematol        ISSN: 0036-553X


  3 in total

1.  Hodgkin lymphoma risk following infectious and chronic inflammatory diseases: a large population-based case-control study from Sweden.

Authors:  Sigurdur Y Kristinsson; Ying Gao; Magnus Björkholm; Sigrun Helga Lund; Jan Sjöberg; Neil Caporaso; Lynn R Goldin; Ola Landgren
Journal:  Int J Hematol       Date:  2015-03-11       Impact factor: 2.490

Review 2.  Hodgkin disease and the role of the immune system.

Authors:  Alana A Kennedy-Nasser; Patrick Hanley; Catherine M Bollard
Journal:  Pediatr Hematol Oncol       Date:  2011-04       Impact factor: 1.969

3.  Lymphocyte function in untreated Hodgkin's disease: an important predictor of prognosis.

Authors:  C Wedelin; M Björkholm; G Holm; S Ogenstad; B Johansson; H Mellstedt
Journal:  Br J Cancer       Date:  1982-01       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.